Spanish competition regulator the CNMC has fined Merck Sharp and Dohme €39m for abusing its dominant position, by blocking Insud Pharma’s rival to the Nuvaring vaginal contraceptive ring through “unjustified legal action” that sought to delay market entry of Insud’s Ornibel version. The originator is considering an appeal.
The CNMC has fined MSD €39m for abuse of dominant position • Source: Shutterstock
Merck Sharp and Dohme has been fined €38.9m ($39.0m) by Spanish competition regulator the CNMC for abusing its dominant position by blocking Insud Pharma’s rival to the Nuvaring vaginal contraceptive ring.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
